Cargando…
SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches
The coronavirus disease 2019 (COVID‐19) is a global infectious disease aroused by RNA virus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Patients may suffer from severe respiratory failure or even die, posing a huge challenge to global public health. Retinoic acid‐inducible gene I (...
Autores principales: | Wang, Mingming, Zhao, Yue, Liu, Juan, Li, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878249/ https://www.ncbi.nlm.nih.gov/pubmed/37521851 http://dx.doi.org/10.1002/mef2.29 |
Ejemplares similares
-
Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity
por: Liu, Yiliu, et al.
Publicado: (2017) -
Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome
por: Cao, Zhongying, et al.
Publicado: (2016) -
Characterization of the Mollusc RIG-I/MAVS Pathway Reveals an Archaic Antiviral Signalling Framework in Invertebrates
por: Huang, Baoyu, et al.
Publicado: (2017) -
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
por: Wu, Jing, et al.
Publicado: (2021) -
Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity
por: Shi, Yuheng, et al.
Publicado: (2017)